Overview
Dysplastic cortical hyperostosis, Kozlowski-Tsuruta type, is an extremely rare bone disorder first described by Kozlowski and Tsuruta. This condition is characterized by abnormal thickening and overgrowth of the outer layer (cortex) of certain bones, a process known as cortical hyperostosis. The condition primarily affects the skeleton, leading to visible and sometimes painful bony enlargements, particularly of the long bones and skull. Affected individuals may notice hard, bony swellings on their limbs or head, and these changes can sometimes be seen on X-rays even before they become noticeable on the outside. Because this disease is so rare, with only a handful of cases reported in the medical literature, our understanding of its full range of symptoms and long-term outcomes is limited. Symptoms may include bone pain, limb deformity, restricted joint movement, and changes in facial appearance if the skull bones are involved. The condition appears to begin in childhood and may progress over time. There is currently no cure or specific treatment for this condition. Management is supportive and focuses on relieving symptoms such as pain, monitoring bone changes with regular imaging, and addressing any complications like joint stiffness or nerve compression through orthopedic or surgical interventions when needed. A team of specialists, including geneticists, orthopedic surgeons, and radiologists, typically work together to manage care.
Also known as:
Key symptoms:
Abnormal thickening of bonesBone painHard bony swellings on limbsThickening of the skull bonesLimited joint movementLimb deformityChanges in facial appearanceUneven bone growthPossible nerve compression from bone overgrowth
Clinical phenotype terms (14)— hover any for plain English
Autosomal recessive
Passed on when both parents carry the same gene change; often skips generations
Childhood
Begins in childhood, roughly ages 1 to 12
Treatments
No FDA-approved treatments are currently listed for Dysplastic cortical hyperostosis, Kozlowski-Tsuruta type.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Dysplastic cortical hyperostosis, Kozlowski-Tsuruta type at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Dysplastic cortical hyperostosis, Kozlowski-Tsuruta type.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Dysplastic cortical hyperostosis, Kozlowski-Tsuruta type.
Community
No community posts yet. Be the first to share your experience with Dysplastic cortical hyperostosis, Kozlowski-Tsuruta type.
Start the conversation →Latest news about Dysplastic cortical hyperostosis, Kozlowski-Tsuruta type
No recent news articles for Dysplastic cortical hyperostosis, Kozlowski-Tsuruta type.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.Which bones are currently affected, and how severe are the changes?,How often should we have imaging done to monitor progression?,What pain management options are safest for long-term use?,Are there any activities my child should avoid to protect their bones?,Should we pursue genetic testing, and would it help with diagnosis or family planning?,Are there any clinical trials or research studies we could participate in?,What signs should prompt us to seek urgent medical attention?
Common questions about Dysplastic cortical hyperostosis, Kozlowski-Tsuruta type
What is Dysplastic cortical hyperostosis, Kozlowski-Tsuruta type?
Dysplastic cortical hyperostosis, Kozlowski-Tsuruta type, is an extremely rare bone disorder first described by Kozlowski and Tsuruta. This condition is characterized by abnormal thickening and overgrowth of the outer layer (cortex) of certain bones, a process known as cortical hyperostosis. The condition primarily affects the skeleton, leading to visible and sometimes painful bony enlargements, particularly of the long bones and skull. Affected individuals may notice hard, bony swellings on their limbs or head, and these changes can sometimes be seen on X-rays even before they become noticeab
How is Dysplastic cortical hyperostosis, Kozlowski-Tsuruta type inherited?
Dysplastic cortical hyperostosis, Kozlowski-Tsuruta type follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Dysplastic cortical hyperostosis, Kozlowski-Tsuruta type typically begin?
Typical onset of Dysplastic cortical hyperostosis, Kozlowski-Tsuruta type is childhood. Age of onset can vary across affected individuals.